EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Mycotoxin Research

ISSN 0178-7888 · Springer Science and Business Media LLC

Latest articles

  1. Efficacy evaluation of a fermented milk containing inactivated biomasses of Lacticaseibacillus rhamnosus and Saccharomyces cerevisiae to ameliorate the toxic effects of dietary aflatoxins and fumonisins in pigs: a pilot study

    Lucas Gabriel Dionisio Freire, Jennifer Rafaela Sá da Silva, Lucas Luiz Assis, Leandra Náira Zambelli Ramalho, Fernando Silva Ramalho, Fabio Enrique Lemos Budiño, Karina Nascimento Pereira, Rogério D’Antonio Pires, Sana Ullah, Sher Ali, Giovana Fumes Ghantous, Roice Eliana Rosim, Carlos Humberto Corassin, Carlos Augusto Fernandes Oliveira

    Published: 2026-11DOI: 10.1007/s12550-026-00677-7

  2. Mycotoxin contamination in food and feed: Occurrence, co-occurrence, combined impacts on human and animal health, climate change implications, risk assessment, and mitigation strategies

    Oluwasola Abayomi Adelusi, Viola Onyinye Okechukwu, Julianah Olayemi Odukoya, Rumbidzai Changwa, Adeola Oluwakemi Aasa, Oluwaseun Mary Oladeji, Nnamdi Nwulu, Kulsum Kondiah, Oluwafemi Ayodeji Adebo, Adewale Olusegun Obadina, Hany S. El-Mesery, Sarah De Saeger, Patrick Berka Njobeh

    Published: 2026-11DOI: 10.1007/s12550-026-00679-5

Volumes

2027 · 22026 · 762025 · 492024 · 562023 · 362022 · 252021 · 352020 · 442019 · 392018 · 332017 · 342016 · 242015 · 252014 · 292013 · 352012 · 332011 · 382010 · 352009 · 322008 · 272007 · 362006 · 482005 · 692004 · 142003 · 442002 · 612001 · 682000 · 771999 · 121998 · 121997 · 191996 · 151995 · 191994 · 171993 · 191992 · 181991 · 531990 · 231989 · 221988 · 28

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.